Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
The Hsp90/Hsp70-based chaperone machinery plays a well-established role in signaling protein function, trafficking and turnover. A number of recent observations also support the notion that Hsp90 and Hsp70 play key roles in the triage of damaged and aberrant proteins for degradation via the ubiquitin-proteasome pathway. In the mid-1990s, it was discovered that Hsp70 is required for ubiquitin-dependent degradation of short-lived and abnormal proteins, and it became clear that inhibition of Hsp90 uniformly leads to the proteasomal degradation of Hsp90 client proteins. Subsequently, CHIP and parkin were shown to be Hsp70-binding ubiquitin E3 ligases that direct ubiquitin-charged E2 enzymes to the Hsp70-bound client protein. Stabilization by Hsp90 reflects the interaction of the chaperone with the ligand binding cleft of the client protein. These hydrophobic clefts must be open to allow passage of ligands to binding sites in the protein interior, and they are inherent sites of conformational instability. Hsp90 stabilizes the open state of the cleft and prevents Hsp70-dependent ubiquitination. In the model we propose here, progressive oxidative events result in cleft opening as the initial step in protein unfolding, and as long as Hsp90 can interact to stabilize the cleft, it will buffer the effect of oxidative damage. When cleft opening is such that Hsp90 can no longer interact, Hsp70-dependent ubiquitination occurs. We summarize evidence that Hsp90 interacts very dynamically with a variety of proteins that are not classic Hsp90 clients, and we show that this dynamic cycling of Hsp90 with nitric oxide synthase protects against CHIP-mediated ubiquitination. Scientific interest to date has focused on stringent regulation of the classic client proteins, which have metastable clefts and are inherently short lived. But, the recognition that Hsp90 cycles dynamically with longer lived proteins with more stable clefts may permit extension of the triage model to the quality control of damaged proteins in general.
Pratt
William B
WB
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, 48109, USA.
Morishima
Yoshihiro
Y
Peng
Hwei-Ming
HM
Osawa
Yoichi
Y
D000251:Adenosine Triphosphatases / Q000737:chemistry; D000818:Animals; D047369:Chromatin Immunoprecipitation; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008954:Models, Biological; D018832:Molecular Chaperones / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D018384:Oxidative Stress; D011485:Protein Binding; D013696:Temperature; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D025801:Ubiquitin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism
D018841:HSP90 Heat-Shock Proteins; D008024:Ligands; D018832:Molecular Chaperones; D016159:Tumor Suppressor Protein p53; D025801:Ubiquitin; D019001:Nitric Oxide Synthase; D044767:Ubiquitin-Protein Ligases; D000251:Adenosine Triphosphatases
Br J Cancer. 2004 Mar;90 Suppl 1:S2-6
15094757
J Biol Chem. 2004 Feb 27;279(9):8389-95
14670946
J Biol Chem. 2001 Feb 2;276(5):3702-8
11071886
J Biol Chem. 2005 Jul 22;280(29):26729-34
15937340
Biochemistry. 2009 Sep 8;48(35):8483-90
19642705
J Natl Cancer Inst. 2002 Apr 3;94(7):504-13
11929951
Cell Growth Differ. 2000 Jul;11(7):355-60
10939589
Cell Signal. 2004 Aug;16(8):857-72
15157665
Curr Opin Genet Dev. 2005 Feb;15(1):55-61
15661534
Nat Rev Cancer. 2005 Oct;5(10):761-72
16175177
Exp Biol Med (Maywood). 2003 Feb;228(2):111-33
12563018
Nat Med. 2005 Oct;11(10):1088-95
16155577
Annu Rev Biochem. 2006;75:271-94
16756493
Cell Mol Life Sci. 2002 Oct;59(10):1640-8
12475174
Mol Endocrinol. 1993 Nov;7(11):1418-29
7906860
Nat Genet. 1999 Dec;23(4):425-8
10581028
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13354-9
11078524
Hum Mol Genet. 2000 Aug 12;9(13):2009-18
10942430
J Biol Chem. 2000 Jul 21;275(29):22268-72
10781589
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14536-41
8962087
Eukaryot Cell. 2005 May;4(5):849-60
15879519
Biochim Biophys Acta. 1999 May 5;1411(2-3):217-30
10320659
Proc Natl Acad Sci U S A. 1992 May 1;89(9):4037-41
1570330
Mol Cell. 2005 May 27;18(5):601-7
15916966
Cell. 1997 Jul 11;90(1):65-75
9230303
J Biol Chem. 1998 May 1;273(18):11183-8
9556607
J Biol Chem. 2004 Dec 17;279(51):52970-7
15466472
Drug Metab Dispos. 1998 May;26(5):497-501
9571232
Anticancer Drug Des. 2000 Feb;15(1):3-16
10888032
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8324-8
8078881
Science. 2002 Mar 8;295(5561):1852-8
11884745
J Clin Invest. 2007 Mar;117(3):648-58
17304350
J Biol Chem. 2006 May 19;281(20):14361-9
16551624
Nat Cell Biol. 2000 Nov;2(11):852-4
11056542
J Biol Chem. 2001 Aug 31;276(35):32663-9
11425855
Nat Cell Biol. 2001 Jan;3(1):93-6
11146632
Nature. 1998 Nov 26;396(6709):336-42
9845070
Nature. 1998 Apr 23;392(6678):821-4
9580552
J Biol Chem. 2001 Nov 16;276(46):42938-44
11557750
EMBO Rep. 2004 Dec;5(12):1165-70
15568014
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8379-83
8710879
Hum Mol Genet. 2002 Mar 1;11(5):515-23
11875046
Nature. 1997 Mar 27;386(6623):414-7
9121560
J Neurosci. 2005 Oct 5;25(40):9152-61
16207874
J Neurosci. 2003 Mar 15;23(6):2203-11
12657679
Cell. 2004 Jan 23;116(2):181-90
14744430
EMBO J. 2004 Feb 11;23(3):659-69
14749733
J Biol Chem. 2004 Nov 19;279(47):48836-45
15358769
Hum Mol Genet. 2001 Jun 1;10(12):1307-15
11406612
J Biol Chem. 1997 Apr 4;272(14):9002-10
9083024
Mol Cell Biol. 2003 Jul;23(14):4948-58
12832480
Biochemistry. 2005 Dec 13;44(49):16333-40
16331994
EMBO Rep. 2001 Oct;2(10):885-90
11600451
J Biol Chem. 2005 Oct 7;280(40):33792-9
16087666
Methods Enzymol. 1991;201:370-9
1658554
Cancer Res. 2003 Jan 1;63(1):39-43
12517775
Mol Pharmacol. 2002 Jul;62(1):110-8
12065761
Hum Mol Genet. 2000 Nov 22;9(19):2811-20
11092757
J Biol Chem. 1993 Feb 5;268(4):2953-9
8428969
Cell. 1998 Aug 21;94(4):471-80
9727490
Trends Biochem Sci. 1996 May;21(5):166-71
8871398
Arch Biochem Biophys. 2009 Mar 1;483(1):66-74
19103148
Physiol Rev. 2002 Apr;82(2):373-428
11917093
Genes Cells. 2004 Jun;9(6):533-48
15189447
Brain Res Mol Brain Res. 2005 Dec 7;142(1):19-27
16216381
Nature. 1992 Jul 9;358(6382):169-70
1614549
Trends Biochem Sci. 2002 Jul;27(7):368-75
12114026
EMBO J. 2002 May 15;21(10):2407-17
12006493
Mutat Res. 1999 Dec 17;431(2):199-209
10635987
J Biol Chem. 2001 Sep 21;276(38):35684-92
11473106
J Biol Chem. 2003 Mar 14;278(11):9339-44
12519764
J Biol Chem. 2003 Aug 15;278(33):30821-7
12799359
J Biol Chem. 2004 May 21;279(21):22483-9
15004035
Am J Physiol Cell Physiol. 2001 Dec;281(6):C1819-24
11698240
Proc Natl Acad Sci U S A. 1981 Feb;78(2):1067-71
6262754
Nature. 2002 Jun 6;417(6889):618-24
12050657
J Biol Chem. 2000 Jun 9;275(23):17407-11
10751385
J Biol Chem. 2003 Jun 13;278(24):22044-55
12676955
Drug Metab Dispos. 2006 Sep;34(9):1448-56
16738031
J Biol Chem. 2008 Jul 4;283(27):18473-7
18442971
EMBO J. 2004 Dec 8;23(24):4813-23
15538384
J Biol Chem. 2003 Sep 19;278(38):36953-8
12855682
Hum Mol Genet. 2008 Dec 15;17(24):3942-52
18784277
Biochem J. 2001 Apr 15;355(Pt 2):357-60
11284722
J Pharmacol Exp Ther. 2003 Feb;304(2):493-7
12538799
Mol Cell Biol. 1996 Sep;16(9):4773-81
8756635
Cell. 2007 Oct 5;131(1):121-35
17923092
Mol Cell Biol. 1986 Jun;6(6):2198-206
3023921
Mol Endocrinol. 2005 Dec;19(12):2901-14
16037132
Mol Cell Biol. 1999 Jun;19(6):4535-45
10330192
Hum Mol Genet. 2006 Jun 1;15(11):1876-83
16644868
Chem Res Toxicol. 1989 May-Jun;2(3):131-41
2519716
J Biol Chem. 1993 Jun 15;268(17):12231-4
7685338
J Biol Chem. 2003 Apr 18;278(16):13829-37
12574167
J Neurosci. 2007 May 9;27(19):5115-26
17494697
Science. 2002 Feb 1;295(5556):865-8
11823645
J Biol Chem. 2005 Mar 25;280(12):11635-40
15664989
Cell Stress Chaperones. 2003 Winter;8(4):303-8
15115282
J Biol Chem. 1999 Jan 15;274(3):1472-8
9880522
Nat Med. 2002 Nov;8(11):1185-6
12411925
Cell. 2005 Mar 11;120(5):715-27
15766533
Trends Biochem Sci. 2000 Jan;25(1):24-8
10637609
Clin Cancer Res. 2000 Aug;6(8):3312-8
10955818
J Biol Chem. 1995 Jul 14;270(28):16580-7
7622464
J Biol Chem. 2004 Jun 11;279(24):25497-502
15044495
Jpn J Cancer Res. 1985 Aug;76(8):672-5
3930444
J Biol Chem. 1999 Dec 3;274(49):34515-8
10574909
Cancer Cell. 2003 Mar;3(3):213-7
12676580
J Biol Chem. 2002 Sep 27;277(39):36223-32
12145311
Mol Endocrinol. 2001 Mar;15(3):421-8
11222743
Bioessays. 2004 Apr;26(4):348-62
15057933
J Biol Chem. 2006 Sep 8;281(36):26714-24
16831871
Annu Rev Genet. 1993;27:437-96
8122909
J Biol Chem. 2005 Jun 24;280(25):23727-34
15845543
Cell. 1997 Apr 18;89(2):239-50
9108479
J Biol Chem. 2008 Aug 22;283(34):22885-9
18515355
Nat Rev Neurosci. 2005 Jan;6(1):11-22
15611723
Annu Rev Biochem. 1998;67:425-79
9759494
Hum Mol Genet. 2004 Jul 1;13(13):1389-405
15115766
J Biol Chem. 2000 Jan 28;275(4):2376-80
10644688
Cell. 1981 Aug;25(2):363-72
6269742
J Biol Chem. 2005 Jul 22;280(29):27443-8
15911628